ES2181608T1 - Procedimiento para la produccion de derivaods de acido hialuronico reticulados de forma multiple. - Google Patents

Procedimiento para la produccion de derivaods de acido hialuronico reticulados de forma multiple.

Info

Publication number
ES2181608T1
ES2181608T1 ES00901776T ES00901776T ES2181608T1 ES 2181608 T1 ES2181608 T1 ES 2181608T1 ES 00901776 T ES00901776 T ES 00901776T ES 00901776 T ES00901776 T ES 00901776T ES 2181608 T1 ES2181608 T1 ES 2181608T1
Authority
ES
Spain
Prior art keywords
production
derivaods
procedure
multiple shaped
hialuronic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES00901776T
Other languages
English (en)
Other versions
ES2181608T9 (es
ES2181608T3 (es
ES2181608T5 (es
Inventor
Xiaobin Fermentech Med Lt Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mentor Biopolymers Ltd
Original Assignee
Vitrolife UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10847046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2181608(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitrolife UK Ltd filed Critical Vitrolife UK Ltd
Publication of ES2181608T1 publication Critical patent/ES2181608T1/es
Publication of ES2181608T3 publication Critical patent/ES2181608T3/es
Application granted granted Critical
Publication of ES2181608T5 publication Critical patent/ES2181608T5/es
Publication of ES2181608T9 publication Critical patent/ES2181608T9/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento para la producción de derivados de ácido hialurónico reticulados de forma múltiple, cuyo procedimiento comprende reticular covalentemente HA por vía de dos o más grupos funcionales diferentes, en donde dicha reticulación se efectúa poniendo en contacto HA con uno o más agentes reticulantes químicos con el fin de formar dos o más reticulaciones químicamente distintas entre dichas moléculas de HA.
ES00901776.5T 1999-02-03 2000-02-03 Procedimiento para la producción de derivados de ácido hialurónico reticulados de forma múltiple Expired - Lifetime ES2181608T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9902412 1999-02-03
GBGB9902412.7A GB9902412D0 (en) 1999-02-03 1999-02-03 Process
PCT/GB2000/000321 WO2000046253A1 (en) 1999-02-03 2000-02-03 Process for the production of multiple cross-linked hyaluronic acid derivatives

Publications (4)

Publication Number Publication Date
ES2181608T1 true ES2181608T1 (es) 2003-03-01
ES2181608T3 ES2181608T3 (es) 2006-06-16
ES2181608T5 ES2181608T5 (es) 2016-07-22
ES2181608T9 ES2181608T9 (es) 2017-02-09

Family

ID=10847046

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00901776.5T Expired - Lifetime ES2181608T5 (es) 1999-02-03 2000-02-03 Procedimiento para la producción de derivados de ácido hialurónico reticulados de forma múltiple

Country Status (15)

Country Link
US (3) US7385052B2 (es)
EP (1) EP1149116B9 (es)
JP (1) JP2002536466A (es)
CN (1) CN1200951C (es)
AT (1) ATE315050T2 (es)
AU (1) AU773518B2 (es)
BR (1) BR0007980A (es)
CA (1) CA2361981C (es)
DE (2) DE1149116T1 (es)
DK (1) DK1149116T5 (es)
ES (1) ES2181608T5 (es)
GB (1) GB9902412D0 (es)
MX (1) MXPA01007876A (es)
NZ (1) NZ512993A (es)
WO (1) WO2000046253A1 (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
US6288043B1 (en) * 1999-06-18 2001-09-11 Orquest, Inc. Injectable hyaluronate-sulfated polysaccharide conjugates
ATE330468T1 (de) 2000-11-03 2006-07-15 Vitrolife Ab Lösung zur evaluierung und konservierung
AU2003284634A1 (en) 2002-11-21 2004-06-15 Chugai Seiyaku Kabushiki Kaisha Sustained release drug carrier
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
AU2003901834A0 (en) 2003-04-17 2003-05-01 Clearcoll Pty Ltd Cross-linked polysaccharide compositions
JPWO2005054302A1 (ja) * 2003-12-05 2007-12-06 中外製薬株式会社 薬物担体及びその製造方法
GB0329907D0 (en) * 2003-12-23 2004-01-28 Innomed Ltd Compositions
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
WO2005112888A2 (en) * 2004-05-20 2005-12-01 Mentor Corporation Methods for making injectable polymer hydrogels
US7651702B2 (en) * 2004-05-20 2010-01-26 Mentor Corporation Crosslinking hyaluronan and chitosanic polymers
US7993678B2 (en) * 2005-09-26 2011-08-09 Novozymes Biopolymer A/S Hyaluronic acid derivatives
DE102006013594A1 (de) * 2006-03-22 2007-09-27 Biopolymer Gmbh & Co. Kg Quervernetzte Gele von Hyaluronsäure und deren Verwendung
CN101153061A (zh) * 2006-09-29 2008-04-02 北京普麦迪克生物技术研究所 一种透明质酸及其二次交联形成凝胶的方法
FR2918377B1 (fr) 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
ES2381417T3 (es) * 2007-09-28 2012-05-28 Shiseido Company, Ltd. Polvo de ácido hialurónico reticulado hinchable y procedimiento para fabricarlo
FR2924615B1 (fr) 2007-12-07 2010-01-22 Vivacy Lab Hydrogel cohesif biodegradable.
ITMC20080129A1 (it) * 2008-07-08 2008-10-07 Phitogen Holding S P A Sintesi di acido ialuronico reticolato con inibitore della ialuronidasi microincapsulato.
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US9371402B2 (en) 2009-04-09 2016-06-21 Scivision Biotech Inc. Method for producing cross-linked hyaluronic acid
US20110081398A1 (en) * 2009-10-01 2011-04-07 Tyco Healthcare Group Lp Multi-mechanism surgical compositions
US8968785B2 (en) * 2009-10-02 2015-03-03 Covidien Lp Surgical compositions
KR101122163B1 (ko) * 2009-12-01 2012-03-16 (주)셀인바이오 아토피 피부염에 효과적인 히알루론산 유도체 및 그 제조방법
HUE030138T2 (en) 2010-03-22 2017-04-28 Allergan Inc Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
IT1399508B1 (it) * 2010-04-22 2013-04-19 Nobil Bio Ricerche Srl Dispositivo per impianto con proprieta' antibatteriche e superficie multifunzionale
ITAN20110138A1 (it) 2011-10-12 2012-01-11 Regenyal Lab S R L Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
KR20140059238A (ko) * 2011-11-11 2014-05-15 미바 메디컬 아이엔시. 주사 시술용 보형물
CN103181902B (zh) * 2011-12-30 2016-06-08 张文芳 一种凝胶微球及其质控方法
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2994846B1 (fr) 2012-08-29 2014-12-26 Vivacy Lab Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
CN102863631B (zh) * 2012-09-29 2013-11-13 杭州嘉伟生物制品有限公司 外科整形用组织填充剂交联透明质酸钠凝胶及其制备方法
CN103055353B (zh) * 2013-01-21 2014-12-24 华熙福瑞达生物医药有限公司 一种手术用防粘连膜的制备方法
CA2916330A1 (en) * 2013-06-28 2014-12-31 Galderma S.A. A process for preparing a cross-linked hyaluronic acid product
RU2640865C2 (ru) * 2013-06-28 2018-01-12 Гальдерма С.А. Способ производства формованного продукта из поперечно-сшитой гиалуроновой кислоты
JP6322192B2 (ja) * 2013-07-08 2018-05-09 デンカ株式会社 コアシェル型架橋ヒアルロン酸ゲル粒子、その製造方法及び医用材料
US9572832B2 (en) * 2013-08-29 2017-02-21 Holy Stone Healthcare Co., Ltd. Compound of glycosaminoglycan and its fabrication method as well as application
US9155757B2 (en) 2013-10-07 2015-10-13 Laboratoires Vivacy Methods and kits for treating vaginal and vulvar vestibule mucosa disorders
FR3015290B1 (fr) 2013-12-23 2017-01-13 Lab Vivacy Compositions d'acide hyaluronique compreant de la mepivacaine
CN103920182B (zh) * 2014-04-16 2015-10-21 华熙福瑞达生物医药有限公司 一种生物可吸收止血膜
US20170290947A1 (en) * 2014-10-08 2017-10-12 Therakine Bio Delivery GmbH Micronized hydrophilic cross-linked biopolymer systems and method of making same
FR3036035B1 (fr) 2015-05-11 2018-10-05 Laboratoires Vivacy Compositions comprenant au moins un polyol et au moins un anesthesique
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
US10130578B2 (en) 2015-07-23 2018-11-20 Johnson & Johnson Consumer Inc. Topical delivery of skin compositions having low pH
WO2017102001A1 (fr) 2015-12-16 2017-06-22 Vplus International Sa Composition d'acide hyaluronique pour injections peniennes
DK4279537T3 (da) 2015-12-29 2026-04-20 Galderma Holding SA Kulhydrat-tværbinder
PT3623390T (pt) 2016-05-31 2023-10-27 Galderma Sa Reticulador de hidrato de carbono
CN106279729A (zh) * 2016-08-26 2017-01-04 北京大清生物技术有限公司 一种透明质酸交联凝胶及其制备方法与应用
KR20180027126A (ko) * 2016-09-06 2018-03-14 (주)한국비엠아이 가교화 히알루론산 유도체 매트릭스가 포함된 지혈 조성물
FR3058064B1 (fr) 2016-10-28 2020-08-07 Lab Vivacy Composition a base d'acide hyaluronique comprenant de la mepivacaine
CZ2016826A3 (cs) 2016-12-22 2018-07-04 Contipro A.S. Léčivý prostředek s nosičem na bázi hyaluronanu a/nebo jeho derivátů, způsob výroby a použití
JP7206281B2 (ja) * 2017-10-12 2023-01-17 ソリープラス ゲゼルシャフト ミット ベシュレンクテル ハフツング 生体高分子の機械的加工
KR102336680B1 (ko) * 2017-11-29 2021-12-08 주식회사 파마리서치 자극의 강도에 따라 변화하는 물성을 가지는 코어-쉘 구조의 히알루론산 겔 및 이의 제조방법
IL306070A (en) * 2018-05-03 2023-11-01 Collplant Ltd Dermal fillers and their uses
IT201800006127A1 (it) * 2018-06-07 2018-09-07 Sintesi di un gel iniettabile (filler) ad alta biocompatibilità a base di Ialuronato di sodio monofasico reticolato e Ialuronato di sodio lineare multifrazionato intercalato.
CN108926736A (zh) * 2018-08-20 2018-12-04 北京化工大学 多糖基组织粘合医用胶及其应用
CN110229357B (zh) * 2019-06-28 2022-03-11 浙江科技学院 一种交联透明质酸凝胶的制备方法
EP4069753A1 (en) 2019-12-02 2022-10-12 Galderma Holding SA High molecular weight esthetic compositions
CN111000796A (zh) * 2019-12-31 2020-04-14 瑞希(重庆)生物科技有限公司 一种透明质酸钠凝胶及其制备方法和应用
FR3111903B1 (fr) 2020-06-24 2022-12-02 Lab Vivacy Procede d’incorporation de composes organiques en solution au sein d’un hydrogel
FR3113522B1 (fr) 2020-08-20 2025-04-18 Lab Vivacy procédé d’évaluation des caractéristiques rhéologiques d’un gel
CN112030566B (zh) * 2020-09-30 2022-10-21 山东华熙海御生物医药有限公司 一种依克多因缓释微囊及其制备方法和应用
CA3208406A1 (en) * 2021-03-02 2022-09-09 Fabien FUCHEZ Implantable or injectable products based on polymers and method for their preparation
CN114478831B (zh) * 2022-01-21 2023-06-27 湖南益安生物科技有限公司 一种高分子材料及其制备方法与应用
CN114716581A (zh) * 2022-03-25 2022-07-08 常州百瑞吉生物医药有限公司 一种多重改性透明质酸衍生物及其应用
FR3135399B1 (fr) 2022-03-30 2025-03-28 Lab Vivacy émulsion comprenant un hydrogel et de la graisse ou un dérivé de graisse
CN115944594B (zh) * 2022-12-30 2024-09-24 东南大学 可载免疫抑制剂的透明质酸明胶复合微球的制备方法
CN116284886B (zh) * 2023-04-10 2024-11-29 上海其胜生物制剂有限公司 多重交联的凝胶体系及其产品、制备方法和应用
FR3162003A1 (fr) 2024-05-12 2025-11-14 Laboratoires Vivacy Composition de biomateriau comprenant un polyhydroxybutyrate sous forme particulaire

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
IT1219587B (it) † 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5800541A (en) 1988-11-21 1998-09-01 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5356883A (en) † 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
GB9024223D0 (en) 1990-11-07 1990-12-19 Fermentech Ltd Production of hyaluronic acid
IT1260154B (it) 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
US5578661A (en) 1994-03-31 1996-11-26 Nepera, Inc. Gel forming system for use as wound dressings
JP3420851B2 (ja) * 1994-12-06 2003-06-30 株式会社資生堂 癒着防止剤
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
US6060534A (en) * 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
EP1162984A2 (en) † 1999-03-15 2001-12-19 Trustees Of Boston University Use of cross linked polysaccharides for the inhibition of angiogenesis

Also Published As

Publication number Publication date
CN1200951C (zh) 2005-05-11
DE60025328T3 (de) 2016-07-28
ES2181608T9 (es) 2017-02-09
DE60025328T2 (de) 2006-09-28
US7385052B2 (en) 2008-06-10
GB9902412D0 (en) 1999-03-24
AU2307500A (en) 2000-08-25
AU773518B2 (en) 2004-05-27
EP1149116B2 (en) 2016-03-30
NZ512993A (en) 2004-02-27
WO2000046253A1 (en) 2000-08-10
EP1149116B1 (en) 2006-01-04
US20050250939A1 (en) 2005-11-10
BR0007980A (pt) 2001-10-30
US8080641B2 (en) 2011-12-20
DK1149116T4 (en) 2016-04-25
MXPA01007876A (es) 2003-06-04
DE60025328D1 (de) 2006-03-30
JP2002536466A (ja) 2002-10-29
DK1149116T3 (da) 2006-05-15
ATE315050T2 (de) 2006-02-15
DE1149116T1 (de) 2002-11-14
EP1149116A1 (en) 2001-10-31
CA2361981C (en) 2008-06-10
EP1149116B9 (en) 2017-01-25
US20090247741A1 (en) 2009-10-01
US20020091251A1 (en) 2002-07-11
CN1342171A (zh) 2002-03-27
ES2181608T3 (es) 2006-06-16
ES2181608T5 (es) 2016-07-22
DK1149116T5 (en) 2017-02-13
CA2361981A1 (en) 2000-08-10
US7514541B2 (en) 2009-04-07

Similar Documents

Publication Publication Date Title
GB9902412D0 (en) Process
GB9902652D0 (en) Process
YU31801A (sh) Amidi antranilne kiseline i njihova upotreba kao leka
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
ES2190653T3 (es) Productos de reaccion del acido hialuronico y de aminoacidos naturales y su utilizacion en composiciones cosmeticas y farmaceuticas.
AU3262597A (en) Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives
TNSN05225A1 (en) 2,4-di(phenylamino) pyrimidines useful in the treatment of neoplastic diseases inflammatory and immune system disorders
IL150257A0 (en) Galactomaninan oligosaccharides, pharmaceutical compositions containing the same and methods for the production thereof
BR9913617A (pt) Composições de reologia modificada e seus processos
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
IT1265101B1 (it) Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico
NZ515891A (en) New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
ES2192680T3 (es) Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
DE59912185D1 (de) Verwendung von hsp70 protein
PT1060175E (pt) Inibidores de triptase
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
IL141325A0 (en) Tan-1057 derivatives
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
MXPA04005552A (es) Analogos de vitamina d.
PT1025082E (pt) Novos derivados de vitamina d com aneis de ciclopropilo nas cadeias laterais processos e produtos intermedios para a sua fabricacao assim como utilizacao para a fabricacao de medicamentos
NO932044L (no) Funksjonaliserte, vinylazolholdige, farmasoeytiske preparater, anvendelse av disse vinylazoler for fremstilling av legemidler, vinylazoler i seg selv, saavel som fremgangsmaater for deres fremstilling
DK0764169T3 (da) Lægemiddelsalte
BG105326A (bg) Нови бензоилгуанидинови производни с преимуществени свойства, метод за тяхното получаване и тяхнотоприложение при производството на лекарствени средства
PT1232173E (pt) Derivados do acido fusidico